Specialized Blood Vessels Jumpstart and Sustain Liver Regeneration

advertisement
News
Articles
Videos
Images
Books
Health & Medicine
Mind & Brain
Plants & Animals
Earth & Climate
Space & Time
Science News
Share
Matter & Energy
Blog
Cite
Specialized Blood Vessels Jumpstart and Sustain Liver Regeneration
ScienceDaily (Nov. 14, 2010) — The liver's unique
ability among organs to regenerate itself has been
little understood. Now Weill Cornell Medical
College scientists have shed light on how the liver
restores itself by demonstrating that endothelial
cells -- the cells that form the lining of blood
vessels -- play a key role.
See Also:
Health & Medicine
 Stem Cells
 Liver Disease
 Immune System
 Leukemia
 Lymphoma
 Prostate Cancer
The results of their study are
published Nov. 10 in the online
edition of the journal Nature, with a
companion study in the Oct. 24 issue
of Nature Cell Biology describing how
endothelial cells are activated to
initiate organ regeneration.
It has long been known that
endothelial cells passively conduct
blood, passing oxygen, nutrients and
Reference
metabolic waste to and from tissues
 Healing
through capillary walls. However, in
 Embryonic stem cell
studies published in recent years, the
 Liver
Weill Cornell researchers have
 Lymphatic system
demonstrated that endothelial cells
actively influence the self-renewal of
certain stem cell populations and the
regeneration of tissue. Now, these
scientists have uncovered the endothelial cells' "instructive role"
in liver regeneration. Further, the researchers believe that in the
coming years it will be possible to facilitate healing damaged
livers by transplanting certain types of endothelial cells with
liver cells.
"We have found that specialized blood vessel cells in the liver -a specific type of sinusoidal endothelial cell -- initiate and
sustain liver regeneration by producing growth factors that we
have identified. This finding will open the door for designing
new therapies to treat damaged livers," says the study's senior
author, Dr. Shahin Rafii, who is the Arthur B. Belfer Professor in
Genetic Medicine and co-director of the Ansary Stem Cell
Institute at Weill Cornell Medical College and a Howard Hughes
Medical Institute investigator.
The liver performs many physiological functions, including
converting nutrients into essential blood components; storing
vitamins and minerals; producing bile for digesting fats;
regulating blood clotting; and metabolizing and detoxifying
substances that would otherwise be harmful. When the liver
malfunctions, the consequences can be grave. Liver failure,
Comp
Ads by Google
Just In:
'Dead' Galaxies A
Science Vide
Phase III Clinical Trial — Enrollment info for PIX-R
TRIAL for relapsed diffuse large B-cell NHL
www.pixrtrial.com
Stem Cell Study - Heart — Now enrolling patients
with heart disease in adult stem cell trial.
www.texasheart.org
Apoptosis and Cell Death — Research ELISAs
from Peviva (800) 526-5224 - US & Canada only
www.diapharma.com
Antibody Microarrays — Microarray platform
consists of over 650 high affinity antibodies
www.springbio.com
Molecular Biolo
Brain Tumors
Ocular Oncolog
Tumors And Sa
An Interactive,
more science
Blood Flow & Circulation — CocoaVia
Supplement Helps Maintain Healthy Blood Flow &
Circulation
CocoaVia.com/Circulation
Related Stories
Liver Regeneration May Be Simpler Than
Previously Thought (Apr. 12, 2007) — The way
the liver renews itself may be simpler than what
scientists had been assuming. A new study provides
information on the inner workings of cells from
regenerating livers that could ... > read more
Miniature Human Livers Created in the
Lab (Oct. 31, 2010) — Researchers have
reached an early, but important, milestone in
the quest to grow replacement livers in the
lab. They are the first to use human liver cells to
successfully engineer miniature livers ... > read
more
Breaking New
Shuttle Endeav
lands after its fi
flight
Daily Rhythms In Blood Vessels May Explain
Morning Peak In Heart Attacks (Nov. 11, 2008) —
Daily rhythms in the activity of cells that line blood
vessels may help explain why heart attacks and
strokes occur most often in early morning hours,
researchers have ... > read more
Special Report:
end to AIDS?
Hepatitis C Is Killing Liver Cells (Feb. 9, 2009) —
It has long been thought that liver disease in
WHO says cell
phone use "pos
carcinogenic"
Not now, dear
female butterfly
closes wings to
avoid sex
more science n
"Until our study, the molecular and cellular pathways that would
initiate and maintain liver regeneration were not known," says
Dr. Bi-Sen Ding, the study's first author and a senior
postdoctoral fellow in Dr. Rafii's lab. "Attempts to transplant
hepatocytes [liver cells] directly into the liver led to very limited
success. But now we have identified liver sinusoidal endothelial
cells (LSECs) -- that, when activated, are critical to liver
regeneration and may enable proper engraftment when
hepatocytes are implanted into the injured liver."
Dr. Rafii's team determined the mechanism by which LSECs
regulate liver regeneration by studying this process in
genetically engineered mice whose livers were 70 percent
removed. Through a series of experiments involving strategic
endothelial cell implantation, the team found that only those
LSECs whose genes were producing the angiocrine growth
factors Id1 or Wnt2 and "hepatocyte growth factor" (HGF)
would initiate and sustain liver regeneration. It is thought that
Wnt2 and HGF work together in initiating regeneration, and that
the LSECs and the liver cells must be next to each other for
successful regeneration were key findings.
"Therefore, to regenerate a long-lasting liver, we may need to
co-transplant hepatocytes with the properly activated
endothelium, which produces the right growth factors for the
hepatocytes to attach, grow and connect with other parts of the
liver. Co-transplantation of primed activated endothelium with
liver cells may be an important step to design future therapies
to regenerate the liver," says Dr. Ding.
Despite these new insights, Dr. Rafii points to an unsolved
enigma: How do endothelial cells sense the loss of liver tissue
and initiate the regeneration process? "Change of blood flow
might be one of the possibilities," suggests Dr. Sina Rabbany,
study co-senior author, who is an adjunct professor at Weill
Cornell and professor of bioengineering at Hofstra University.
"It is well known that endothelial cells can sense subtle
changes in the flow of blood because they are located at the
interface between the blood flow and vessel wall. The loss of a
liver lobe will inevitably alter the local blood flow patterns and
resulting shear stresses that are redirected into the remaining
lobes. This alteration in the biomechanical transduction process
is part of a complex system likely to 'activate' endothelial cells
to produce hepatocyte-active growth factors."
Stem Cell Technology Used in Unique Surgery
(May 9, 2011) — For the first time, researchers in
Sweden have produced a blood vessel from stem
cells and then used it in an operation on a 10-yearold girl. Surgeons were able to create a new
connection with the ... > read more
Stem Cells Speed Growth Of Healthy Liver
Tissue (Mar. 28, 2007) — For the first time,
researchers have used adult bone marrow stem
cells to regenerate healthy human liver tissue,
according to a study published in the April issue of
the journal ... > read more
In Other News
Mladic must fac
crimes charges
prosecutor
Greece nears
IMF/EU deal an
dismisses drac
talk
Egypt presiden
sons to be tried
August 3: sourc
Healthy Blood Vessels May Prevent Fat Growth
(Sep. 23, 2008) — Cells lining blood vessels may
perform an unsuspected task -- controlling the
development of fat cells. Researchers found that
precursor or stem cells have a markedly reduced
tendency to develop into ... > read more
Special report:
Monterrey falls,
Mexico falls
Sunitinib May Slow Growth And Spread Of Liver
Cancer (Apr. 14, 2008) — Treatment with sunitinib
slows tumor growth and reduces the risk of
metastasis in patients with hepatocellular
carcinoma, an aggressive cancer of the liver,
researchers ... > read more
Dead Syrian bo
emerges as sym
for protesters
Ads by Google
ALCL Legal Information — Breast Impants and
Lymphoma Ask Our Experienced Trial Lawyers
www.seglaw.com
Private sector j
growth slumps
May
U.N. urges Jap
nuclear safety
overhaul after
Fukushima
Western push o
Syria may spar
divisive IAEA d
more top news
Urology Supplies — Eliminate the Hassles of
Medicare & Ins. Billing for Urology Supplies!
www.LiberatorMedical.com
Naringenin — Naringenin can stop HCV Stops
transmission of Hepatitis c
AlternativeMedicineSolution.com
Stem Cell Antibodies — Sox2, NANOG, KLF4,
OCT4, LRG5 Samples Available!
www.abgent.com/
Dr. David Lyden, a co-author on the paper and the Stavros
San Francisco Hospital — California Pacific
Niarchos Associate Professor in Pediatric Cardiology at Weill
Medical Center Providing Leading-edge Medicine
Cornell Medical College, says, "This is an important study. By
www.cpmc.org
targeting endothelial-specific genes such as Id1, as identified in
this research, I hope that it will facilitate the design of new
therapies to treat people with liver disease, whether due to
Number of stories in
infection, cancer, or acute or long-term damage."
Search ScienceDaily
archives: 103,480
Earlier this year, Rafii's team developed a new technique and
described a novel mechanism for turning human embryonic and
pluripotent stem cells into plentiful, functional endothelial cells,
which are critical to the formation of blood vessels. The new
approach allows scientists to generate virtually unlimited
quantities of durable endothelial cells -- more than 40-fold the
Copyright Reut
Free Subscrip
Get the latest scie
newsletters, upda
hourly updated ne
Email Newslett
RSS Newsfeed
Feedback
Tell us what you t
welcome both po
Have any problem
in this study and director and physician-in-chief of the Ronald
O. Perelman and Claudia Cohen Center for Reproductive
Medicine, as well as the director of the Tri-Institutional Stem
Cell Initiative Derivation Unit at Weill Cornell Medical College.
"One of the most remarkable findings of our studies is the
realization that endothelial cells within each organ are
functionally different, and once activated produce a unique set
of growth factors," states Dr. Rafii. "The challenge that lies
ahead is to discover the organ-specific growth factors produced
by the endothelial cells that initiate the regeneration of that
particular organ. Then, these factors could be exploited
therapeutically to induce selective regeneration of one organ
without affecting others."
Additional co-authors include Daniel J. Nolan, Jason M. Butler,
Daylon James, Alexander O. Babazadeh and Koji Shido, all of
the Ansary Stem Cell Institute in the Department of Genetic
Medicine, Weill Cornell Medical College, and the Howard
Hughes Medical Institute; Dr. Vivek Mittal, Department of
Surgery, Weill Cornell Medical College; and Dr. Thomas N.
Sato, Graduate School of Biological Sciences, Nara Institute of
Science and Technology, Nara, Japan.
How Vascular Endothelial Cells Renew Blood Stem Cells
and Control Stem Cells' Differentiation
Another study by the same group, published in the Oct. 24
issue of Nature Cell Biology, examines how a similar type of
sinusoidal endothelial cells that promote liver regeneration also
are activated to renew blood stem cells and control their
differentiation into various types of blood cells within the bone
marrow. The findings may be used to create mass quantities of
stem cells following trauma to the bone marrow's
microenvironment.
Following injury from therapeutic radiation or chemotherapy,
stem cells in the bone marrow are injured, hampering blood cell
production. Some patients experience severe and potentially
irreversible trauma to their ability to produce blood cells. Until
now it has been unclear how the body signals these stem cells
to regenerate and to differentiate into cells that form blood cells.
Dr. Rafii and his lab have shown that endothelial cells release
specific angiocrine growth factors into the environment of the
bone marrow, telling the body to produce more stem cells. The
researchers showed that the Akt-pathway is activated in the
endothelial cells, which turns on expression of a group of
growth factors that induces the bone marrow to produce more
stem cells. Following the activation of the Akt-pathway, the
MAP kinase pathway is activated, which stimulates the
production of angiocrine factors that control the differentiation
of the stem cells into various cells needed to make up blood.
Results from the study show a 10-fold increase of stem cell
production in mouse models that express higher levels of Akt
selectively in endothelial cells, when compared with control
mice. If proven applicable in humans, the findings may lead to a
new way of treating patients suffering from bone marrow
deficiencies.
Dr. Jason Butler, who along with Dr. Hideki Kobayashi is the
study's co-first author and senior postdoctoral fellows in Dr.
Rafii's lab.
"Using properly activated organ-specific endothelial cells to
propagate enough stem and progenitor cells, such as those of
bone marrow and liver, so they can be used clinically has broad
therapeutic implications not only for regenerative medicine, but
also for the study of genetic diseases," concludes Dr. Rafii.
Additional co-authors include Mariko Kobayashi, Bi-Sen Ding,
Bryant Bonner, Vi Chiu, Daniel Nolan, Koji Shido, all from Weill
Cornell; and Laura Benjamin and Rebekah O'Donnell, from the
Beth Israel Deaconess Medical Center, Harvard Medical
School, Boston, Mass.
The Nature and Nature Cell Biology studies were both
supported by grants from the Howard Hughes Medical Institute,
the Ansary Stem Cell Institute, the National Institutes of Health,
Qatar National Priorities Research Program, the Anbinder
Foundation, Newman's Own Foundation, the Empire State
Stem Cell Board, and the New York State Department of
Health.
Email or share this story:
| More
Story Source:
The above story is reprinted (with editorial adaptations by
ScienceDaily staff) from materials provided by NewYorkPresbyterian Hospital/Weill Cornell Medical College, via
Newswise.
Journal References:
1. Bi-Sen Ding, Daniel J. Nolan, Jason M. Butler, Daylon
James, Alexander O. Babazadeh, Zev Rosenwaks, Vivek
Mittal, Hideki Kobayashi, Koji Shido, David Lyden, Thomas
N. Sato, Sina Y. Rabbany, Shahin Rafii. Inductive
angiocrine signals from sinusoidal endothelium are
required for liver regeneration. Nature, 2010; DOI:
10.1038/nature09493
2. Hideki Kobayashi, Jason M. Butler, Rebekah O'Donnell,
Mariko Kobayashi, Bi-Sen Ding, Bryant Bonner, Vi K. Chiu,
Daniel J. Nolan, Koji Shido, Laura Benjamin, Shahin Rafii.
Angiocrine factors from Akt-activated endothelial cells
balance self-renewal and differentiation of
haematopoietic stem cells. Nature Cell Biology, 2010; 12
(11): 1046 DOI: 10.1038/ncb2108
Need to cite this story in your essay, paper, or report? Use
one of the following formats:
i APA
j
k
l
m
n
j MLA
k
l
m
n
NewYork-Presbyterian Hospital/Weill Cornell
Medical College (2010, November 14).
Specialized blood vessels jumpstart and sustain
liver regeneration. ScienceDaily. Retrieved June
1, 2011, from http://www.sciencedaily.com
Find with keyword(s):
Disclaimer: This article is not intended to provide medical
advice, diagnosis or treatment. Views expressed here do not
necessarily reflect those of ScienceDaily or its staff.
Enter a keyword or phrase to search ScienceDaily's
archives for related news topics,
the latest news stories, reference articles, science
videos, images, and books.
About ScienceDaily® | Editorial Staff | Awards & Reviews | Contribute News | Advertise With Us | Privacy Policy | Terms of Use
Copyright © 1995-2010 ScienceDaily LLC — All rights reserved — Contact: editor@sciencedaily.com
Note: This web site is not intended to provide medical advice, diagnosis or treatment.
Part of the iVillage Your Total Health Network
Download